XML 22 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Ordinary shares
Share premium
Other equity reserves
Accumulated deficit
Total
Balance at Dec. 31, 2021 $ 91,112 $ 16,732 $ (83,657) $ 24,187
Balance (in Shares) at Dec. 31, 2021 30,000,339        
Exercise of options 64 (64)
Exercise of options (in Shares) 46,561        
Exercise of pre-funded warrants 492 (492)
Exercise of pre-funded warrants (in Shares) 260,000        
Expiration of options 2,255 (2,255)
Share-based payments 2,171 2,171
Issuance of shares for service provider 104 104
Issuance of shares for service provider (in Shares) 140,135        
Issuance of shares related to payment of earn-out consideration 1,050 (1,050)
Issuance of shares related to payment of earn-out consideration (in Shares) 2,181,009        
Net profit (loss) for the year (13,151) (13,151)
Balance at Dec. 31, 2022 95,077 15,042 (96,808) 13,311
Balance (in Shares) at Dec. 31, 2022 32,628,044        
Exercise of options 188 (165) 23
Exercise of options (in Shares) 224,463        
Exercise of warrants 561 (232) 329
Exercise of warrants (in Shares) 1,258,420        
Expiration of options 259 (259)
Repurchase of warrants related to the O.R.B. agreement 274 (640) (366)
Share-based payments 975 975
At-the-market offering, net of issuance costs of $164 604 604
At-the-market offering, net of issuance costs of $164 (in Shares) 2,393,740        
Private placement, net of issuance costs of $499 thousand 2,563 151 2,714
Private placement, net of issuance costs of $499 thousand (in Shares) 18,722,420        
Classification of warrants issued under private placement to equity 1,116 1,116
Issuance of shares related to payment of earn-out consideration 1,050 (1,050)
Issuance of shares related to payment of earn-out consideration (in Shares) 4,454,545        
Net profit (loss) for the year (5,525) (5,525)
Balance at Dec. 31, 2023 100,576 14,938 (102,333) 13,181
Balance (in Shares) at Dec. 31, 2023 59,681,632        
Exercise of options and vesting of RSUs 5,404 (2,204) 3,200
Exercise of options and vesting of RSUs (in Shares) 3,426,777        
Exercise of warrants 3,636 (1,383) 2,253
Exercise of warrants (in Shares) 6,035,860        
Expiration of options 19 (19)
Expiration of warrants 2,257 (2,257)
Share-based payments 2,017 2,017
Net profit (loss) for the year 5,780 5,780
Other comprehensive loss for the year (80) (80)
Balance at Dec. 31, 2024 $ 111,892 $ 11,012 $ (96,553) $ 26,351
Balance (in Shares) at Dec. 31, 2024 69,144,269